These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35857038)

  • 41. LncRNA HAND2-AS1 inhibits 5-fluorouracil resistance by modulating miR-20a/PDCD4 axis in colorectal cancer.
    Jiang Z; Li L; Hou Z; Liu W; Wang H; Zhou T; Li Y; Chen S
    Cell Signal; 2020 Feb; 66():109483. PubMed ID: 31760170
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 1,3-Bis(2-chloroethyl)-1-nitrosourea enhances the inhibitory effect of resveratrol on 5-fluorouracil sensitive/resistant colon cancer cells.
    Das D; Preet R; Mohapatra P; Satapathy SR; Kundu CN
    World J Gastroenterol; 2013 Nov; 19(42):7374-88. PubMed ID: 24259968
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patrinia scabiosaefolia Inhibits Growth of 5-FU-Resistant Colorectal Carcinoma Cells via Induction of Apoptosis and Suppression of AKT Pathway.
    Huang SZ; Liu WY; Huang Y; Shen AL; Liu LY; Peng J
    Chin J Integr Med; 2019 Feb; 25(2):116-121. PubMed ID: 29948597
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hexahydrocurcumin enhances inhibitory effect of 5-fluorouracil on HT-29 human colon cancer cells.
    Srimuangwong K; Tocharus C; Yoysungnoen Chintana P; Suksamrarn A; Tocharus J
    World J Gastroenterol; 2012 May; 18(19):2383-9. PubMed ID: 22654430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metformin Inhibited Proliferation and Metastasis of Colorectal Cancer and presented a Synergistic Effect on 5-FU.
    Sang J; Tang R; Yang M; Sun Q
    Biomed Res Int; 2020; 2020():9312149. PubMed ID: 32851092
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells.
    Fiore D; Proto MC; Pisanti S; Picardi P; Pagano Zottola AC; Butini S; Gemma S; Casagni A; Laezza C; Vitale M; Ligresti A; Di Marzo V; Zisterer DM; Nathwani S; Williams DC; Campiani G; Gazzerro P; Bifulco M
    Cancer Biol Ther; 2016 Aug; 17(8):849-58. PubMed ID: 26392056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glycolysis is essential for chemoresistance induced by transient receptor potential channel C5 in colorectal cancer.
    Wang T; Ning K; Sun X; Zhang C; Jin LF; Hua D
    BMC Cancer; 2018 Feb; 18(1):207. PubMed ID: 29463225
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of semaphorin 4D enhances chemosensitivity by increasing 5-fluorouracile-induced apoptosis in colorectal cancer cells.
    Rashidi G; Rezaeepoor M; Mohammadi C; Solgi G; Najafi R
    Mol Biol Rep; 2020 Sep; 47(9):7017-7027. PubMed ID: 32888127
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lapatinib, a dual inhibitor of EGFR and HER2, has synergistic effects with 5-fluorouracil on esophageal carcinoma.
    Guo XF; Zhu XF; Zhong GS; Deng BG; Gao ZT; Wang H
    Oncol Rep; 2012 May; 27(5):1639-45. PubMed ID: 22293713
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Esculetin enhances the inhibitory effect of 5-Fluorouracil on the proliferation, migration and epithelial-mesenchymal transition of colorectal cancer.
    Yan L; Yu HH; Liu YS; Wang YS; Zhao WH
    Cancer Biomark; 2019; 24(2):231-240. PubMed ID: 30689555
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro additive antitumor effects of dimethoxycurcumin and 5-fluorouracil in colon cancer cells.
    Zhao H; Liu Q; Wang S; Dai F; Cheng X; Cheng X; Chen W; Zhang M; Chen D
    Cancer Med; 2017 Jul; 6(7):1698-1706. PubMed ID: 28573788
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Icariin-mediated inhibition of NF-κB activity enhances the in vitro and in vivo antitumour effect of 5-fluorouracil in colorectal cancer.
    Shi DB; Li XX; Zheng HT; Li DW; Cai GX; Peng JJ; Gu WL; Guan ZQ; Xu Y; Cai SJ
    Cell Biochem Biophys; 2014 Jul; 69(3):523-30. PubMed ID: 24435883
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synergistic anticancer properties of docosahexaenoic acid and 5-fluorouracil through interference with energy metabolism and cell cycle arrest in human gastric cancer cell line AGS cells.
    Gao K; Liang Q; Zhao ZH; Li YF; Wang SF
    World J Gastroenterol; 2016 Mar; 22(10):2971-80. PubMed ID: 26973393
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autophagy inhibition by chloroquine sensitizes HT-29 colorectal cancer cells to concurrent chemoradiation.
    Schonewolf CA; Mehta M; Schiff D; Wu H; Haffty BG; Karantza V; Jabbour SK
    World J Gastrointest Oncol; 2014 Mar; 6(3):74-82. PubMed ID: 24653797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antitumor Activity of Zinc Nanoparticles Synthesized with Berberine on Human Epithelial Colorectal Adenocarcinoma (Caco-2) Cells through Acting on Cox-2/NF-kB and p53 Pathways.
    Othman MS; Al-Bagawi AH; Obeidat ST; Fareid MA; Habotta OA; Moneim AEA
    Anticancer Agents Med Chem; 2022; 22(10):2002-2010. PubMed ID: 34607550
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Olaparib-mediated enhancement of 5-fluorouracil cytotoxicity in mismatch repair deficient colorectal cancer cells.
    de Castro E Gloria H; Jesuíno Nogueira L; Bencke Grudzinski P; da Costa Ghignatti PV; Guecheva TN; Motta Leguisamo N; Saffi J
    BMC Cancer; 2021 Apr; 21(1):448. PubMed ID: 33888065
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of the Wnt/b-catenin pathway using PNU-74654 reduces tumor growth in in vitro and in vivo models of colorectal cancer.
    Amerizadeh F; Rahmani F; Maftooh M; Nasiri SN; Hassanian SM; Giovannetti E; Moradi-Marjaneh R; Sabbaghzadeh R; Shahidsales S; Joudi-Mashhad M; Ghayour-Mobarhan M; Ferns GA; Khazaei M; Avan A
    Tissue Cell; 2022 Aug; 77():101853. PubMed ID: 35803035
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells.
    Wen C; Chen J; Zhang D; Wang H; Che J; Qin Q; He L; Cai Z; Lin M; Lou Q; Huang L; Chen D; Iwamoto A; Ren D; Wang L; Lan P; Wang J; Liu H; Yang X
    Cancer Lett; 2016 Dec; 383(2):295-308. PubMed ID: 27713084
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Wogonin potentiates the antitumor effects of low dose 5-fluorouracil against gastric cancer through induction of apoptosis by down-regulation of NF-kappaB and regulation of its metabolism.
    Zhao Q; Wang J; Zou MJ; Hu R; Zhao L; Qiang L; Rong JJ; You QD; Guo QL
    Toxicol Lett; 2010 Sep; 197(3):201-10. PubMed ID: 20570612
    [TBL] [Abstract][Full Text] [Related]  

  • 60. miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4.
    Azar MRMH; Aghazadeh H; Mohammed HN; Sara MRS; Hosseini A; Shomali N; Tamjidifar R; Tarzi S; Mansouri M; Sarand SP; Marofi F; Akbari M; Xu H; Shotorbani SS
    Int Immunopharmacol; 2021 Mar; 92():107355. PubMed ID: 33429333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.